-
-
-
-
-
-
-
Cipher Pharmaceuticals Responds to Request for Comment from IIROC
-
-
-
-
-
-
-
Cipher Pharmaceuticals Announces Preliminary Q2 2016 Results Highlighted by 30+% Revenue Growth and $3.0+million Cash from Operations
-
-
-
-
-
-
-
Cipher Pharmaceuticals Reports Q1 2016 Financial Results
-
-
-
-
-
-
-
Cipher Pharma's (CPHR) Dermadexin and Pruridexin Approved in Canada
-
-
-
-
-
-
-
Cipher Pharma (CPHR) Launches Actikerall in Canada
-
-
-
-
-
-
-
Cipher Receives Health Canada Approval of (Pr)Beteflam™
-
-
-
-
-
-
-
Cipher Pharmaceuticals Strengthens Leadership Team with Key Executive Appointments and Announces Launch of Vaniqa® in Canada
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

